Significantly, STAT5 has been identified as a major downstream signaling mediator of constitutively activated SYK, both in vitro and in vivo, and targeted deletion of Stat5 in vivo was shown to fully abrogate AML caused by TEL-SYK [24]. This evidence concerns the gene SYK and acute myeloid leukemia.